Skip to main content
. Author manuscript; available in PMC: 2011 Jan 21.
Published in final edited form as: Arch Neurol. 2006 Oct 9;63(12):1709–1717. doi: 10.1001/archneur.63.12.noc60109

Table 3.

Odds Ratios for Subjects With Alzheimer Disease vs Nondemented Subjects by Mediterranean Diet Score in Continuous and Tertile Form

Model Nondemented, No. AD, No. MeDi Continuous OR (95% CI) P Value MeDi Tertiles OR (95% CI) P for Trend
1* 1790 194 0.81 (0.74–0.88) <.001 Low 1 (Reference) <.001
Middle 0.58 (0.42–0.81)
High 0.40 (0.26–0.61)
2 1300 137 0.76 (0.67–0.87) <.001 Low 1 (Reference) <.001
Middle 0.47 (0.29–0.76)
High 0.32 (0.17–0.59)
3 1259 135 0.76 (0.66–0.86) <.001 Low 1 (Reference) <.001
Middle 0.48 (0.29–0.79)
High 0.31 (0.16–0.58)

Abbreviations: AD, Alzheimer disease; CI, confidence interval; MeDi, Mediterranean diet; OR, odds ratio.

*

Model 1 is unadjusted.

Model 2 is adjusted for cohort, age, sex, ethnicity, education, apolipoprotein E genotype, caloric intake, smoking, comorbidity index, and body mass index (calculated as weight in kilograms divided by height in meters squared).

Model 3 is adjusted for all variables of model 2 plus the following additional vascular variables: history of stroke, diabetes mellitus, hypertension, and heart disease and plasma levels of total cholesterol, high-density lipoprotein, triglycerides, and low-density lipoprotein.